dengyuemed (25)in #chinapharma • 2 days agoChina’s Innovative Drugs: A Long Road from Local Breakthroughs to Global ImpactIn the past few years, China’s pharmaceutical industry has begun to attract worldwide attention. Headlines now speak…dengyuemed (25)in #keymedbio • 4 days agoCaught Between Giants: How Can Keymed Biosciences’ Stapokibart Injection Break Through the Competition?On September 12, 2024, Keymed Biosciences announced that its independently developed Category 1 innovative drug…dengyuemed (25)in #chinesemedicine • 5 days agoA Traveler's Guide to Purchasing Innovative Chinese Medicines in ChinaTraveling to China offers more than just iconic landmarks like the Great Wall or bustling cities like Shanghai—it's…dengyuemed (25)in #drugapproval • 6 days agoChina NMPA Approves Xeligekimab Injection (Jinlixi) for Moderate-to-Severe Plaque PsoriasisOn September 12, 2024, China’s NMPA officially approved Xeligekimab Injection (Jinlixi), developed by Chongqing…dengyuemed (25)in #oncology • 7 days agoChina’s Oncology Innovation Gains Momentum: Golixitinib Approved for r/r PTCLExciting news from China’s biopharma sector — the NMPA has conditionally approved Golixitinib Capsules (Gaoruizhe)…dengyuemed (25)in #innovativedrugs • 9 days agoChina’s Innovative Drug Exports: From “Made in China” to “Created in China”I’m Dengyuemed, a passionate observer of tech and healthcare trends. Today, I’m thrilled to dive into a topic that’s…
